Origin Therapeutics Sponsoring Microdose Psychedelic Capital Conference

2 years ago

Origin Therapeutics’ portfolio company, Microdose Psychedelic Insights, will host the Microdose Psychedelic Capital event virtually on March 24Vancouver, British Columbia,…

Cost, Access are Biggest Barriers to OUD Recovery, But Telemedicine Can Help, According to New Report from Bicycle Health

2 years ago

100% of respondents believe that telemedicine-supported Medication-Assisted Treatment should remain available even after the pandemic comes to an endBOSTON, March…

Novolyze Raises $15 Million to Improve Food Safety Globally

2 years ago

BETHESDA, Md., March 23, 2022 (GLOBE NEWSWIRE) -- Bethesda, Maryland- and Dijon, France-based food safety and quality scale-up Novolyze announced today…

TransCode Therapeutics Announces Article Published in the Journal Cancers Detailing the Potential for Short RNA-based Drugs in Cancer and a Broad Range of Disorders

2 years ago

BOSTON, March 23, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer…

Exhale Wellness: 50 States Legal Weed Cannabinoid Stirs up the Cannabis Industry

2 years ago

GLENDALE, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- A large number of legal hemp suppliers satisfy the appetites of hemp…

Anika to Showcase its Transformation into a Global Leader in Joint Preservation during the 2022 AAOS Annual Meeting

2 years ago

Anika is an innovative joint preservation company focused on the early intervention orthopedic continuum of care including OA pain management,…

Panbela to Participate in a Panel Discussion: “Pancreatic Cancer- Turning the Tide for One of the Most Challenging Indications in Oncology,” at the Maxim Virtual Growth Conference on March 28, 2022, at 12:00 pm ET

2 years ago

MINNEAPOLIS, March 23, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for…

Heat Biologics Announces Appointment of Greg Burel, Former Director of the Strategic National Stockpile, to its Biothreat Advisory Board and as Senior Advisor to the Company

2 years ago

Burel to support anthrax and RapidVax™ biodefense initiatives as a platform for rapid response to known and unknown biological threatsDURHAM,…

Allogene Therapeutics Announces Preclinical Publication Highlighting Superiority of Healthy Donor-Derived Allogeneic CAR T Cells Over Patient-Derived Cells in Multiple Myeloma

2 years ago

Results Demonstrated Anti-BCMA CAR T Cells Derived from Healthy Donors Had Better Immune Fitness and Killing ActivityPhase 1 AlloCAR T™…

AIM ImmunoTech to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

2 years ago

Company to participate in live panel, “Pancreatic Cancer: Turning the Tide for One of the Most Challenging Indications in Oncology,”…